These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19528349)

  • 1. Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation.
    Chen J; Kobayashi M; Darmanin S; Qiao Y; Gully C; Zhao R; Kondo S; Wang H; Wang H; Yeung SC; Lee MH
    Am J Pathol; 2009 Jul; 175(1):400-11. PubMed ID: 19528349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pim-1 plays a pivotal role in hypoxia-induced chemoresistance.
    Chen J; Kobayashi M; Darmanin S; Qiao Y; Gully C; Zhao R; Yeung SC; Lee MH
    Oncogene; 2009 Jul; 28(28):2581-92. PubMed ID: 19483729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines.
    Block KM; Hanke NT; Maine EA; Baker AF
    Pancreas; 2012 Jul; 41(5):773-81. PubMed ID: 22273698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why target PIM1 for cancer diagnosis and treatment?
    Magnuson NS; Wang Z; Ding G; Reeves R
    Future Oncol; 2010 Sep; 6(9):1461-78. PubMed ID: 20919829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
    Kim J; Roh M; Abdulkadir SA
    BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents.
    Casillas AL; Toth RK; Sainz AG; Singh N; Desai AA; Kraft AS; Warfel NA
    Clin Cancer Res; 2018 Jan; 24(1):169-180. PubMed ID: 29084916
    [No Abstract]   [Full Text] [Related]  

  • 7. PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species.
    Warfel NA; Sainz AG; Song JH; Kraft AS
    Mol Cancer Ther; 2016 Jul; 15(7):1637-47. PubMed ID: 27196781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase.
    Zhang Y; Lei W; Yan W; Li X; Wang X; Zhao Z; Hui J; Shen Z; Yang J
    Stem Cell Res Ther; 2016 Apr; 7(1):61. PubMed ID: 27103465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity.
    Wang YY; Taniguchi T; Baba T; Li YY; Ishibashi H; Mukaida N
    Cancer Sci; 2012 Jan; 103(1):107-15. PubMed ID: 21981263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants.
    Chen K; Yang J; Li J; Wang X; Chen Y; Huang S; Chen JL
    Oncotarget; 2016 Mar; 7(9):10073-89. PubMed ID: 26848623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. eIF4B phosphorylation by pim kinases plays a critical role in cellular transformation by Abl oncogenes.
    Yang J; Wang J; Chen K; Guo G; Xi R; Rothman PB; Whitten D; Zhang L; Huang S; Chen JL
    Cancer Res; 2013 Aug; 73(15):4898-908. PubMed ID: 23749639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28.
    Toth RK; Solomon R; Warfel NA
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth.
    Padi SKR; Singh N; Bearss JJ; Olive V; Song JH; Cardó-Vila M; Kraft AS; Okumura K
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20505-20510. PubMed ID: 31548394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.
    Blanco FF; Jimbo M; Wulfkuhle J; Gallagher I; Deng J; Enyenihi L; Meisner-Kober N; Londin E; Rigoutsos I; Sawicki JA; Risbud MV; Witkiewicz AK; McCue PA; Jiang W; Rui H; Yeo CJ; Petricoin E; Winter JM; Brody JR
    Oncogene; 2016 May; 35(19):2529-41. PubMed ID: 26387536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pim-1 kinase protects P-glycoprotein from degradation and enables its glycosylation and cell surface expression.
    Xie Y; Burcu M; Linn DE; Qiu Y; Baer MR
    Mol Pharmacol; 2010 Aug; 78(2):310-8. PubMed ID: 20460432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pivotal role for Pim-1 kinase in esophageal squamous cell carcinoma involving cell apoptosis induced by reducing Akt phosphorylation.
    Li S; Xi Y; Zhang H; Wang Y; Wang X; Liu H; Chen K
    Oncol Rep; 2010 Oct; 24(4):997-1004. PubMed ID: 20811681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
    Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
    Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proto-oncogene Pim-1 is a target of miR-33a.
    Thomas M; Lange-Grünweller K; Weirauch U; Gutsch D; Aigner A; Grünweller A; Hartmann RK
    Oncogene; 2012 Feb; 31(7):918-28. PubMed ID: 21743487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pim-1 expression and monoclonal antibody targeting in human leukemia cell lines.
    Li J; Hu XF; Loveland BE; Xing PX
    Exp Hematol; 2009 Nov; 37(11):1284-94. PubMed ID: 19703513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival.
    Kim KT; Baird K; Ahn JY; Meltzer P; Lilly M; Levis M; Small D
    Blood; 2005 Feb; 105(4):1759-67. PubMed ID: 15498859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.